Simple Risk Score Model Helps Wean Patients from Mechanical Circulatory Support
By HospiMedica International staff writers Posted on 23 Oct 2024 |

Patients experiencing severe heart failure or cardiogenic shock often require support from mechanical circulatory support (MCS) devices, such as venoarterial extracorporeal membrane oxygenation (VA-ECMO) or the IMPELLA heart pump. These devices help ensure adequate blood flow to vital organs when the heart is too weak to function independently. A crucial part of the recovery process for these patients is assessing when their heart has regained enough strength to operate on its own, allowing for a gradual reduction in external support or weaning off the devices. Currently, physicians determine whether a patient can be weaned off MCS by monitoring essential health indicators, including blood pressure, cardiac output, and left ventricular ejection fraction (LVEF), which assess the heart's ability to pump blood effectively. Although these parameters are recognized as important for guiding the weaning process, there is a lack of standardized protocols or guidelines, making the decision of when to safely wean patients a significant challenge. Researchers have now developed a simple risk score model that utilizes easily measurable health indicators to predict the success of MCS weaning.
Instead of relying on complicated and invasive tests to assess heart function, the method developed by researchers from Shinshu University School of Medicine (Nagano, Japan) is simple and safe, making it feasible to implement for most hospitals. In their study published in Journal of Cardiac Failure, the researchers proposed a simple risk score to predict the successful weaning of patients with cardiogenic shock from MCS. They utilized metrics that guide the weaning process from real-world clinical data to formulate the risk score. Conducting a retrospective single-center cohort study, the researchers analyzed data from 114 patients with cardiogenic shock who received treatment with either VA-ECMO or the IMPELLA heart pump between January 2013 and June 2023. They evaluated patient data and outcomes related to weaning decisions made by a multidisciplinary heart team, which included cardiologists and cardiovascular surgeons. A patient was deemed successfully weaned from MCS if the device was removed (or decannulation was performed) without the need for re-implantation and the patient survived until discharge from the hospital.
Out of the total cohort, 86 patients underwent the weaning procedure, and 55 were successfully weaned off MCS. Those who were not weaned had a higher incidence of acute myocardial infarction (AMI) and poorer health indicators. Their average blood pressure was lower (71 mm Hg) compared to those who successfully weaned (85 mm Hg), and they had a reduced pulse pressure (38 ± 20 mm Hg versus 50 ± 19 mm Hg) and weaker heart function (30% versus 40% LVEF). Additionally, they presented with elevated lactate levels in their blood (11 mg/dL versus 9 mg/dL) and longer QRS durations (106 ms vs. 92 ms), indicating slower electrical activity in the heart's ventricles. Utilizing these variables (AMI, mean blood pressure, lactate, QRS duration, and LVEF), the researchers developed two risk score formulas: one for general weaning and a simplified version.
The simplified version, known as the simple MCS weaning score, classifies patients into five groups based on their success rates by summing the points linked to each risk factor. A score of 0 or 1 indicates the absence of risk factors, corresponding to a 100% success rate; 2 points reflect two risk factors, with an 81% success rate; 3 points signify three risk factors with a 63% success rate; 4 points relate to an 11% success rate; and 5 points indicate a 0% success rate. The health indicators incorporated into the formula for this score are easily measurable with standard medical equipment, rendering the risk-scoring method practical and accessible for most hospitals.
“We propose a score model that can accurately predict successful weaning from MCS in patients with cardiogenic shock,” said Clinical Fellow Sho Suzuki who led the research team. “Interestingly, this score can be used to make bedside predictions about weaning, considering advanced therapy, or withdrawing the patient from care. We are looking forward to further research on such non-invasive methods for weaning patients and hope to establish a prediction model that successfully predicts weaning without the need for hemodynamic assessments.”
Related Links:
Shinshu University School of Medicine
Latest Critical Care News
- Novel Coating Significantly Extends Longevity of Implantable Biosensors
- Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
- New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
- Battery-Powered Wearable Device Monitors Joint Pain
- Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws
- Breakthrough Sensor Technology Tracks Stroke After Effects
- New Study Demonstrates AI-Assisted Detection of Reduced Ejection Fraction
- Novel 3D Adipose Tissue Bioprinting Method to Find Applications in Regenerative Medicine
- Miniaturized Pacemaker for Newborns Found Safe and Effective for Up to Two Years
- World’s First 3D Neural Electrode Uses Soft Actuation Technology to Avoid Nerve Damage
- Smartwatch Algorithm Detects Cardiac Arrest
- Blood-Brain Barrier “Organ Chip” Treats Brain Tumors Unreachable by Chemotherapy
- AI Model Could Use ECG Tests to Detect Premature Aging and Cognitive Decline
- World-First Technology Uses Real-Time ECG Signal Analysis for Accurate CVAD Placement
- AI Outperforms Humans at Analyzing Long-Term ECG Recordings
- Smart Sensor Enables Precise, Self-Powered Tracking of Healing Wounds
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more